The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly

The Predictors for asthma control by stepwise treatment during 6 months in Korean elderly

Completed

Looking for future studies?

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

60 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Wŏnju, Gangwon-do, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients aged 60 years or more, articulate in Korean
Patients diagnosed with asthma, at least 1 year in duration.

Exclusion criteria

Patients being followed-up for asthma treatment less than 1 year before baseline
Patients taking immune therapy
Patients previously enrolled/randomized in the present clinical trial

Treatment and study plan

Primary outcomes

Baseline characteristics related to asthma control in the elderly

Time frame: 6 months
Asthma exacerbation rate of the elderly during guideline-based stepwise treatments

Time frame: 6 months

Secondary outcomes

1. Proportion of controlled, partially controlled, and controlled patients among the elderly patients with asthma in Korea

Time frame: 6 months
2. Baseline characteristics related to asthma specific QOL in the elderly patients with asthma

Time frame: 6 months
Mean frequency of PFT, sputum assessments, refill adherence(%), prescription persistence in elderly asthma for the last 1 year before study enrollment

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: Prelude

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2012
First posted: Jun 10, 2011
Registry last updated: Jan 14, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed